GRANUPAS

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug GRANUPAS contains one active pharmaceutical ingredient (API):

1 P-Aminosalicylic acid UNII 5B2658E0N2 - AMINOSALICYLIC ACID

Aminosalicylic acid is bacteriostatic against Mycobacterium tuberculosis. It inhibits the onset of bacterial resistance to streptomycin and isoniazid. Read about 4-Aminosalicylic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J04AA01	Aminosalicylic acid	J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AA Aminosalicylic acid and derivatives
Discover more medicines within J04AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1644982
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 034602
Country: FR	Base de données publique des médicaments	Identifier(s): 64667202
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 263966
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7982
Country: IT	Agenzia del Farmaco	Identifier(s): 043376019
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1073158
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100316579